Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Real-time Estimate Tradegate 09:57:35 2024-03-28 am EDT 5-day change 1st Jan Change
8.395 EUR +1.19% Intraday chart for Grifols, S.A. -0.40% -45.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Close Mixed in Friday Trading; UK Regulator Probes Vodafone, Three UK Proposed Merger MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading MT
Grifols' Financial Reports Have No Major Accounting Mistakes, Spanish Regulator Says MT
Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Ahead of Powell Speech MT
European shares set for weekly gains; UK's Phoenix soars RE
U.S. Futures Flat, European Stocks Mixed DJ
Spanish Securities Regulator Finds No Significant Errors in Grifols' Financial Reports MT
Spain's supervisor CNMV finds no significant errors in Grifols accounts RE
Grifols not required to restate accounts, says Spain's stock market regulator RE
CNMV: AT PRESENT, IT'S NOT POSSIBLE TO PREJUDGE POTENTIAL CONSEQ… RE
CNMV: HAVE NOT FOUND EVIDENCE THAT THE FINANCIAL DEBT REPORTED B… RE
SPANISH STOCK MARKET SUPERVISOR CNMV: INVESTIGATIONS NOT IDENTIF… RE
European Equities Traded in the US as American Depositary Receipts Ease Wednesday MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading MT
Sector Update: Health Care Stocks Retreating Late Afternoon MT
Grifols Downgraded by Fitch, S&P on Lower Cash Flows -- Shares Fall MT
Fitch Downgrades Grifols on Deleveraging Woes, Refinancing Risks MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
Shares in Spanish drugmaker Grifols tumble on Fitch, S&P downgrades RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading MT
US Futures, European Stocks Fall Ahead of U.S. Inflation Data DJ
ADRs Close Lower, Lixiang Education Holding Co. Ltd. Declines 19.6% DJ
European Equities Traded in the US as American Depositary Receipts Decline Friday MT
Chart Grifols, S.A.
More charts
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (84.3%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (10.2%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.1%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.5%), European Union (13.6%), the United States and Canada (59.1%) and other (21.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
8.296 EUR
Average target price
18.76 EUR
Spread / Average Target
+126.17%
Consensus
  1. Stock
  2. Equities
  3. Stock Grifols, S.A. - BME
  4. News Grifols, S.A.
  5. Grifols Forecasts Strong Revenue Growth in H2 Amid HIgher Plasma Collection